Peter E. Cross

1.4k total citations
33 papers, 1.1k citations indexed

About

Peter E. Cross is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Peter E. Cross has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Organic Chemistry, 15 papers in Molecular Biology and 9 papers in Pharmacology. Recurrent topics in Peter E. Cross's work include Inorganic and Organometallic Chemistry (5 papers), Phenothiazines and Benzothiazines Synthesis and Activities (5 papers) and Synthesis and Reactions of Organic Compounds (4 papers). Peter E. Cross is often cited by papers focused on Inorganic and Organometallic Chemistry (5 papers), Phenothiazines and Benzothiazines Synthesis and Activities (5 papers) and Synthesis and Reactions of Organic Compounds (4 papers). Peter E. Cross collaborates with scholars based in United Kingdom and United States. Peter E. Cross's co-authors include Roger A. Burges, Kenneth J. Blackburn, John Arrowsmith, Simon F. Campbell, Donald G. Gardiner, Roger P. Dickinson, M. J. PARRY, Michael Gwilt, Michael J. Randall and A. J. Birch and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Thrombosis and Haemostasis.

In The Last Decade

Peter E. Cross

30 papers receiving 1.0k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Peter E. Cross 442 441 365 168 106 33 1.1k
Samuel Chackalamannil 504 1.1× 848 1.9× 311 0.9× 137 0.8× 104 1.0× 75 1.7k
Takehiko Naka 733 1.7× 621 1.4× 411 1.1× 104 0.6× 54 0.5× 38 1.5k
David A. Claremon 538 1.2× 992 2.2× 231 0.6× 183 1.1× 73 0.7× 50 1.7k
Gregory J. Wells 697 1.6× 971 2.2× 306 0.8× 57 0.3× 99 0.9× 54 1.9k
Yasuhisa Kohara 359 0.8× 473 1.1× 370 1.0× 76 0.5× 45 0.4× 14 1.0k
Yoshiyuki Inada 522 1.2× 413 0.9× 412 1.1× 192 1.1× 97 0.9× 35 1.4k
Sung‐Eun Yoo 548 1.2× 592 1.3× 100 0.3× 130 0.8× 148 1.4× 107 1.4k
Norman Whittaker 302 0.7× 403 0.9× 145 0.4× 430 2.6× 43 0.4× 27 1.1k
Hisashi Shinkai 573 1.3× 291 0.7× 66 0.2× 217 1.3× 127 1.2× 27 1.6k
Klaus Rehse 368 0.8× 661 1.5× 57 0.2× 163 1.0× 95 0.9× 155 1.2k

Countries citing papers authored by Peter E. Cross

Since Specialization
Citations

This map shows the geographic impact of Peter E. Cross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter E. Cross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter E. Cross more than expected).

Fields of papers citing papers by Peter E. Cross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter E. Cross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter E. Cross. The network helps show where Peter E. Cross may publish in the future.

Co-authorship network of co-authors of Peter E. Cross

This figure shows the co-authorship network connecting the top 25 collaborators of Peter E. Cross. A scholar is included among the top collaborators of Peter E. Cross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter E. Cross. Peter E. Cross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Walker, Don K., G. Wynne Aherne, John Arrowsmith, et al.. (1991). Measurement of the class III antidysrhythmic drug, UK-68,798, in plasma by radioimmunoassay. Journal of Pharmaceutical and Biomedical Analysis. 9(2). 141–149. 25 indexed citations
4.
Gwilt, Michael, H. W. Dalrymple, Roger A. Burges, et al.. (1991). Electrophysiologic Properties of UK-66,914, a Novel Class III Antiarrhythmic Agent. Journal of Cardiovascular Pharmacology. 17(3). 376–385. 26 indexed citations
5.
Gwilt, Michael, John Arrowsmith, Kenneth J. Blackburn, et al.. (1990). UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells.. Journal of Pharmacology and Experimental Therapeutics. 256(1). 318–324. 165 indexed citations
6.
Cross, Peter E., et al.. (1990). Selective class III antiarrhythmic agents. 1. Bis(arylalkyl)amines. Journal of Medicinal Chemistry. 33(4). 1151–1155. 44 indexed citations
7.
8.
9.
Alker, David, et al.. (1989). Long-acting dihydropyridine calcium antagonists. 3. Synthesis and structure-activity relationships for a series of 2-[(heterocyclylmethoxy)methyl] derivatives. Journal of Medicinal Chemistry. 32(10). 2381–2388. 25 indexed citations
10.
Arrowsmith, John, Simon F. Campbell, Peter E. Cross, Roger A. Burges, & Donald G. Gardiner. (1989). Long acting dihydropyridine calcium antagonists. 2. 2-[2-aminoheterocycloethoxy]methyl derivatives. Journal of Medicinal Chemistry. 32(3). 562–568. 16 indexed citations
11.
Cross, Peter E., Roger P. Dickinson, M. J. PARRY, & Michael J. Randall. (1986). Selective thromboxane synthetase inhibitors. 3. 1H-Imidazol-1-yl-substituted benzo[b]furan-, benzo[b]thiophene- and indole-2- and 3-carboxylic acids. Journal of Medicinal Chemistry. 29(9). 1637–1643. 12 indexed citations
12.
Arrowsmith, John, Simon F. Campbell, Peter E. Cross, et al.. (1986). Long-acting dihydropyridine calcium antagonists. 1. 2-Alkoxymethyl derivatives incorporating basic substituents. Journal of Medicinal Chemistry. 29(9). 1696–1702. 194 indexed citations
13.
Cross, Peter E., Roger P. Dickinson, M. J. PARRY, & Michael J. Randall. (1985). Selective thromboxane synthetase inhibitors. 1. 1-[(Aryloxy)alkyl]-1H-imidazoles. Journal of Medicinal Chemistry. 28(10). 1427–1432. 30 indexed citations
14.
PARRY, M. J., et al.. (1981). UK-37,248, A Novel, Selective Thromboxane Synthetase Inhibitor With Anti-Aggregatory And Anti-Thrombotic Activity. Thrombosis and Haemostasis. 2 indexed citations
15.
Barnish, I. T., Peter E. Cross, Roger P. Dickinson, M. J. PARRY, & Michael J. Randall. (1981). Cerebrovasodilatation through selective inhibition of the enzyme carbonic anhydrase. 3. 5-(Arylthio)-, 5-(arylsulfinyl)-, and 5-(arylsulfonyl)thiophene-2-sulfonamides. Journal of Medicinal Chemistry. 24(8). 959–964. 9 indexed citations
16.
Randall, Michael J., et al.. (1981). UK-37,248, A novel, selective thromboxane synthetase inhibitor with platelet anti-aggregatory and anti-thrombotic activity. Thrombosis Research. 23(1-2). 145–162. 96 indexed citations
17.
Cross, Peter E., et al.. (1978). Cerebrovasodilatation through selective inhibition of the enzyme carbonic anhydrase. 1. Substituted benzenedisulfonamides. Journal of Medicinal Chemistry. 21(9). 845–850. 13 indexed citations
18.
Cross, Peter E., et al.. (1977). Compounds with gastric antisecretory activity. 1. Phenoxyalkylamines. Journal of Medicinal Chemistry. 20(10). 1317–1323. 1 indexed citations
19.
Birch, Arthur J., Peter E. Cross, D. T. CONNOR, & G. S. R. Subba Rao. (1966). Steroid hormones. Part XVI. Some organometallic and 3-deoxysteroids. Journal of the Chemical Society C Organic. 1. 54–54. 6 indexed citations
20.
Birch, A. J., et al.. (1965). Reactions of some metal carbonyls with 1-methoxycyclohexa-1,4-diene and related compounds. Chemical Communications (London). 366–366. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Samuel Chackalamannil Breakdown of academic impact, for papers by Takehiko Naka Breakdown of academic impact, for papers by David A. Claremon Breakdown of academic impact, for papers by Gregory J. Wells Breakdown of academic impact, for papers by Yasuhisa Kohara Breakdown of academic impact, for papers by Yoshiyuki Inada Breakdown of academic impact, for papers by Sung‐Eun Yoo Breakdown of academic impact, for papers by Norman Whittaker Breakdown of academic impact, for papers by Hisashi Shinkai Breakdown of academic impact, for papers by Klaus Rehse
Rankless by CCL
2026